Aug. 29, 2024
The U.S. Food and Drug Administration (FDA) this week provided notice of final guidance issued by the Center for Devices and Radiological Health, Mammography Quality Standards Act (MQSA) and Regulation Amendments: Small Entity Compliance Guide (SECG). The FDA developed the SECG to explain the actions a small entity must take to comply with the MQSA rule and its implementing regulations.

The March 2023 MQSA rule modernized mammography regulations and specifies that the mammography report given to patients specifies if they have dense or non-dense breast tissue; it includes a prescribed paragraph on the significance of breast density.

The FDA prepared the SECG to help small entities comply with MQSA regulation changes, which take effect Sept. 10.

For more information, contact Katie Grady, American College of Radiology® Government Affairs Director.

Related ACR News

  • ACR Urges CMS to Address Radiology Needs in 2026 HOPPS Rule

    ACR urges CMS to establish clear AI payment pathways in SaaS policy and calls for increased reimbursement for essential radiology services.

    Read more
  • ACR Champions Bill to Grow Physician Workforce

    ACR supports bipartisan bill to boost U.S. healthcare by recapturing unused visas for international doctors and nurses.

    Read more
  • HHS Issues Alert on Info Blocking Enforcement

    HHS issued an enforcement alert that info blocking rules still apply. ACR has radiology-focused guidance and FAQs available.

    Read more